See Young Lee

Dr. See Young Lee

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2024 in Gut and Liver
Verified
Journal Article
Open access
PDF file
SLSee Young Lee
See Young Lee
SJSung Ill Jang
Sung Ill Jang
JCJae Hee Cho
Jae Hee Cho
MDMin Young Do
Min Young Do
SLSu Yeon Lee
Su Yeon Lee
DLDong Ki Lee
Dong Ki Lee
See Young Lee, Sung Ill Jang, Jae Hee Cho, Min Young Do, Su Yeon Lee, Arong Choi, Hye Sun Lee, Juyeon Yang, Dong Ki Lee. Gut and Liver -0001;0:. https://doi.org/10.5009/gnl230494

14 November 2023 in Cancers
Verified
Journal Article
Open access
PDF file
SJSung Ill Jang
Sung Ill Jang
JNJi Hae Nahm
Ji Hae Nahm
SLSee Young Lee
See Young Lee
JCJae Hee Cho
Jae Hee Cho
MDMin-Young Do
Min-Young Do
DLDong Ki Lee
Dong Ki Lee
The serum level of CA 19-9 is a prognostic marker for pancreatic ductal adenocarcinoma (PDAC). We evaluated the ability of the expression level of methionyl-tRNA synthetase 1 (MARS1)—which facilitates cancer growth by modulating protein synthesis and the cell cycle—to predict the prognosis of PDAC. Immunohistochemical (IHC) staining was performed on pancreatic specimens obtained from patients with PDAC who were undergoing surgery. High MARS1 expression was defined as equal to, or greater than, that in normal acinar cells. Low MARS1 expression was defined as weaker than in normal acinar cells, and stronger than in the pancreatic duct epithelium. Univariate and multivariate analyses were performed on other factors related to prognosis. Among 137 PDAC patients, no significant differences in baseline characteristics were found between those with high (n = 82) and low (n = 55) MARS1 expression. The median overall survival time of patients with high MARS1 expression was shorter than that of those with low expression (15.2 versus 17.2 months, log-rank test p = 0.044). The median disease-free survival (DFS) was not significantly different between the two groups. However, the DFS was shorter in patients with high than in those with low MARS1 expression (8.9 versus 11.2 months, log-rank test p = 0.067). In a multivariate analysis, lymph node metastasis and high MARS1 expression were associated with a poor prognosis of PDAC. Elevated MARS1 expression detected by IHC staining is associated with a poor prognosis of PDAC, suggesting that MARS1 has potential as a prognostic marker.

10 April 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SLSee Young Lee
See Young Lee
JNJi Hae Nahm
Ji Hae Nahm
MKMin-Jae Kim
Min-Jae Kim
YKYuna Kim
Yuna Kim
JKJie-Hyun Kim
Jie-Hyun Kim
HPHyojin Park
Hyojin Park
Background: Eosinophilic esophagitis (EoE) is a disease that has been subcategorized into two endoscopic phenotypes: inflammatory and fibrostenotic. Moreover, studies have shown a link between EoE and immunoglobulin G4 (IgG4), a subclass of the immunoglobulin G (IgG) antibody. In this study, we aimed to evaluate the relationship between histologic IgG4 expression and endoscopic phenotypes in patients with EoE. Methods: This case-control study included patients diagnosed with EoE (n = 19) and patients with non-obstructive dysphagia without abnormal findings as controls (NOD; n = 12). The EoE group was further divided into three subgroups based on endoscopic phenotype: inflammatory, fibrostenotic, or combined. Retrospective examination of endoscopic findings and pathological slides was performed to analyze IgG4 staining. Results: Histological analysis revealed a significant difference in IgG4 cell count (15.00 vs. 0.58, p = 0.003) and eosinophil cell count (84.67 vs. 0.08, p < 0.001) between the EoE and NOD groups. Symptom manifestation and blood test results were similar across all three endoscopic EoE phenotypes. However, histological analysis revealed a significant difference in IgG4 cell count between the inflammatory, fibrostenotic, and combined phenotypes (4.13 vs. 17.6 vs. 59.7, p = 0.030). Conclusions: IgG4 expression was higher in EoE patients than in those with NOD, the highest being in the combined phenotype subgroup. These findings emphasize the important role of endoscopic and histological examination in diagnosing EoE and the need for further research in this area.

20 February 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SLSee Young Lee
See Young Lee
SJSung Ill Jang
Sung Ill Jang
MCMoon Jae Chung
Moon Jae Chung
JCJae Hee Cho
Jae Hee Cho
MDMin-Young Do
Min-Young Do
DLDong Ki Lee
Dong Ki Lee
Background: This study evaluated the effectiveness of short fully covered self-expanding metal stents (FCSEMS) with an anti-migration design in treating benign biliary strictures (BBS) not related to living donor liver transplantation (LDLT). Methods: A retrospective analysis was conducted on 75 patients who underwent FCSEMS insertion for BBS management. Stents were initially kept for 3 months and exchanged every 3 months until stricture resolution. Adverse events and stricture recurrence after FCSEMS removal were assessed during follow-up. Results: The study outcomes were technical success, stenosis resolution, and treatment failure. Technical success was 100%, with stricture resolution in 99% of patients. The mean onset time of BBS post-surgery was 4.4 years, with an average stent indwelling period of 5.5 months. Stricture recurrence occurred in 20% of patients, mostly approximately 18.8 months after stent removal. Early cholangitis and stent migration were noted in 3% and 4% of patients, respectively. Conclusions: This study concludes that short FCSEMS demonstrate high efficacy in the treatment of non-LDLT-related BBS, with a low incidence of interventions and complications. Although this is a single-center, retrospective study with a limited sample size, the findings provide preliminary evidence supporting the use of short FCSEMS as a primary treatment modality for BBS. To substantiate these findings, further research involving multicenter studies is recommended to provide additional validation and a broader perspective.

24 September 2024 in Pancreatology
Verified
Journal Article
Closed access
SLSee Young Lee
See Young Lee
JLJaein Lee
Jaein Lee
JCJae Hee Cho
Jae Hee Cho
DLDong Ki Lee
Dong Ki Lee
YSYeseul Seong
Yeseul Seong
SJSung Ill Jang
Sung Ill Jang

1 March 2025 in Magnetic Medicine
Verified
Journal Article
Open access
SLSee Young Lee
See Young Lee
SJSung Ill Jang
Sung Ill Jang
JCJae Hee Cho
Jae Hee Cho
JJJung Hyun Jo
Jung Hyun Jo
CJChan Min Jung
Chan Min Jung
DLDong Ki Lee
Dong Ki Lee